Simplex Trading’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $148K | Buy |
17,700
+16,700
| +1,670% | +$175K | ﹤0.01% | 4647 |
|
|
2025
Q4 | $14.4K | Sell |
1,000
-14,000
| -93% | -$174K | ﹤0.01% | 6746 |
|
|
2025
Q3 | $144K | Sell |
15,000
-12,200
| -45% | -$108K | ﹤0.01% | 5332 |
|
|
2025
Q2 | $223K | Buy |
27,200
+15,500
| +132% | +$130K | ﹤0.01% | 4393 |
|
|
2025
Q1 | $83K | Buy |
11,700
+6,500
| +125% | +$48.4K | ﹤0.01% | 5260 |
|
|
2024
Q4 | $40K | Sell |
5,200
-1,400
| -21% | -$13.1K | ﹤0.01% | 6099 |
|
|
2024
Q3 | $69K | Sell |
6,600
-8,800
| -57% | -$107K | ﹤0.01% | 5584 |
|
|
2024
Q2 | $180K | Buy |
15,400
+7,500
| +95% | +$117K | ﹤0.01% | 4755 |
|
|
2024
Q1 | $166K | Buy |
7,900
+3,400
| +76% | +$60.5K | ﹤0.01% | 5059 |
|
|
2023
Q4 | $80K | Buy |
4,500
+4,000
| +800% | +$70.5K | ﹤0.01% | 5610 |
|
|
2023
Q3 | $8K | Sell |
500
-6,800
| -93% | -$123K | ﹤0.01% | 7358 |
|
|
2023
Q2 | $145K | Sell |
7,300
-4,200
| -37% | -$80.9K | ﹤0.01% | 4655 |
|
|
2023
Q1 | $217K | Buy |
11,500
+6,200
| +117% | +$137K | ﹤0.01% | 4227 |
|
|
2022
Q4 | $120K | Buy |
5,300
+4,300
| +430% | +$97.2K | ﹤0.01% | 4860 |
|
|
2022
Q3 | $26K | Buy |
1,000
+600
| +150% | +$17.8K | ﹤0.01% | 7241 |
|
|
2022
Q2 | $9K | Sell |
400
-300
| -43% | -$7.5K | ﹤0.01% | 8388 |
|
|
2022
Q1 | $23K | Sell |
700
-1,700
| -71% | -$47.2K | ﹤0.01% | 8101 |
|
|
2021
Q4 | $78K | Sell |
2,400
-300
| -11% | -$10.2K | ﹤0.01% | 6630 |
|
|
2021
Q3 | $106K | Hold |
2,700
| – | – | ﹤0.01% | 6539 |
|
|
2021
Q2 | $104K | Buy |
2,700
+2,694
| +44,900% | +$96.4K | ﹤0.01% | 6677 |
|
|
2021
Q1 | $20K | Sell |
6
-149
| -96% | -$6.36K | ﹤0.01% | 7455 |
|
|
2020
Q4 | $703K | Buy |
155
+141
| +1,007% | +$4.93K | ﹤0.01% | 2998 |
|
|
2020
Q3 | $38K | Sell |
14
-119
| -89% | -$3.88K | ﹤0.01% | 5876 |
|
|
2020
Q2 | $489K | Sell |
133
-16
| -11% | -$596 | ﹤0.01% | 2934 |
|
|
2020
Q1 | $482K | Sell |
149
-186
| -56% | -$7.75K | ﹤0.01% | 2630 |
|
|
2019
Q4 | $1.37M | Sell |
335
-58
| -15% | -$2.29K | ﹤0.01% | 1800 |
|
|
2019
Q3 | $1.4M | Buy |
393
+252
| +179% | +$10.2K | ﹤0.01% | 1631 |
|
|
2019
Q2 | $724K | Sell |
141
-30
| -18% | -$1.5K | ﹤0.01% | 2222 |
|
|
2019
Q1 | $980K | Buy |
171
+124
| +264% | +$6.14K | ﹤0.01% | 2013 |
|
|
2018
Q4 | $197K | Sell |
47
-104
| -69% | -$6.1K | ﹤0.01% | 3180 |
|
|
2018
Q3 | $1.14M | Buy |
151
+89
| +144% | +$6.41K | ﹤0.01% | 1761 |
|
|
2018
Q2 | $444K | Sell |
62
-24
| -28% | -$1.15K | ﹤0.01% | 2584 |
|
|
2018
Q1 | $14K | Buy |
86
+57
| +197% | +$1.66K | ﹤0.01% | 3714 |
|
|
2017
Q4 | $18K | Sell |
29
-31
| -52% | -$934 | ﹤0.01% | 3397 |
|
|
2017
Q3 | $63K | Buy |
60
+37
| +161% | +$833 | ﹤0.01% | 2092 |
|
|
2017
Q2 | $7K | Buy |
+23
| New | +$445 | ﹤0.01% | 4321 |
|
Other funds holding RGNX
RG
VCM
IHAM
Simplex Trading's RGNX Position: Q1 2026 in Review
Simplex Trading sold out of Regenxbio (RGNX) in Q1 2026, closing a stake of 6,234 shares — an estimated $65.5K sold.
Simplex Trading first reported a position in RGNX in Q4 2017 and held it in 22 quarters. The position peaked at $2.12M in Q4 2020. 178 funds tracked by Wall St. Rank hold RGNX as of Q1 2026.
- Simplex Trading reported no remaining Regenxbio position as of Q1 2026 after selling out during the quarter.
- Simplex Trading sold 6,234 Regenxbio shares in Q1 2026, an estimated $65.5K.
- Simplex Trading first reported a position in Regenxbio in Q4 2017 and held it in 22 quarters.
- Simplex Trading's Regenxbio position peaked at $2.12M in Q4 2020.
- 178 funds tracked by Wall St. Rank held Regenxbio as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.